Human prion diseases: Molecular, cellular and population biology

Neuropathology

Volumn 33, Issue 3, 2013, Pages 221-236

  Head, Mark W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Creutzfeldt Jakob disease; Disease transmission; Epigenetic; in vitro models; Prion

Indexed keywords

PRION PROTEIN; PROTEINASE;

ARTICLE; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CELL THERAPY; CHRONIC WASTING DISEASE; CLINICAL DECISION MAKING; CREUTZFELDT JAKOB DISEASE; CYTOLOGY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EMBRYONIC STEM CELL; EPIGENETICS; FATAL FAMILIAL INSOMNIA; FELINE SPONGIFORM ENCEPHALOPATHY; GENOTYPE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; INFECTION RISK; KURU; MOLECULAR BIOLOGY; NEUROTOXICITY; NONHUMAN; OPEN READING FRAME; PATHOGENICITY; PHENOTYPE; PHENOTYPIC VARIATION; POPULATION BIOLOGY; PREVALENCE; PRION DISEASE; PRIORITY JOURNAL; PUBLIC HEALTH; SCRAPIE; SECONDARY INFECTION; SPORADIC CREUTZFELDT JAKOB DISEASE; STEM CELL TRANSPLANTATION; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TISSUE TRANSPLANTATION; TRANSMISSIBLE MINK ENCEPHALOPATHY; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE; VASCULAR AMYLOIDOSIS; WESTERN BLOTTING; ZOONOSIS;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; EPIGENESIS, GENETIC; HUMANS; NERVOUS SYSTEM DISEASES; PEPTIDE HYDROLASES; POPULATION; PRION DISEASES; PRIONS; PRPC PROTEINS; RISK FACTORS; ZOONOSES;

EID: 84878625625     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12016     Document Type: Article

References (110)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-13383.
3. Si K, Choi YB, White-Grindley E, Majumdar A, Kandel ER. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 2010; 140: 421-435.
4. Wickner RB, Shewmaker F, Edskes H etal. Prion amyloid structure explains templating: how proteins can be genes. FEMS Yeast Res 2010; 10: 980-991.
5. Prusiner SB. Cell biology: a unifying role for prions in neurodegenerative diseases. Science 2012; 336: 1511-1513.
6. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318: 930-936.
7. Parchi P, Cescatti M, Notari S etal. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 2010; 133: 3030-3042.
8. Gambetti P, Cali I, Notari S, Kong Q etal. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol 2011; 121: 79-90.
9. Haik S, Brandel JP. Biochemical and strain properties of CJD prions: complexity versus simplicity. J Neurochem 2011; 119: 251-261.
10. Telling GC, Parchi P, DeArmond SJ etal. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274: 2079-2082.
11. Mastrianni JA. The genetics of prion diseases. Genet Med 2010; 12: 187-195.
12. Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem 2011; 305: 1-22.
13. Brandner S, Isenmann S, Raeber A etal. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379: 339-343.
14. Raeber AJ, Race RE, Brandner S etal. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to scrapie. EMBO J 1997; 16: 6057-6065.
15. Hill AF, Butterworth RJ, Joiner S etal. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183-189.
16. Hilton DA, Ghani AC, Conyers L etal. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733-739.
17. Collinge J, Whitfield J, McKintosh E etal. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 2006; 367: 2068-2074.
18. Wadsworth JDF, Joiner S, Lineham JM etal. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci USA 2008; 105: 3885-3890.
19. Brown P, Brandel JP, Sato T etal. Iatrogenic Creutzfeldt-Jakob disease, the final assessment. Emerg Infect Dis 2012; 18: 901-907.
20. The National CJD Research & Surveillance Unit (NCJDRSU), The University of Edinburgh. [Cited 27 December 2012.] Available from URL: http://www.cjd.ed.ac.uk/documents/figs.pdf
21. The National CJD Research & Surveillance Unit (NCJDRSU), The University of Edinburgh. [Cited 27 December 2012.] Available from URL: http://www.cjd.ed.ac.uk/documents/worldfigs.pdf
22. Kaski D, Mead S, Hyare H etal. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374: 2128.
23. Health Protection Report, Health Protection Agency. [Cited 27 December 2012.] Available from URL: http://www.hpa.org.uk/hpr/archives/2012/news3212.htm#bnrmlprn
24. Ironside JW, Bishop MT, Connolly K etal. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 2006; 332: 1186-1188.
25. Llewelyn CA, Hewitt PE, Knight RS etal. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421.
26. The National CJD Research & Surveillance Unit (NCJDRSU), The University of Edinburgh. [Cited 27 December 2012.] Available from URL: http://www.cjd.ed.ac.uk/TMER/TMER.htm
27. Wroe SJ, Pal S, Siddique D etal. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368: 2061-2067.
28. Head MW, Yull HM, Ritchie DL, Bishop MT, Ironside JW. Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2009; 35: 433-436.
29. Peden AH, Head MW, Ritchie DR, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-529.
30. Peden A, McCardle L, Head MW etal. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16: 296-304.
31. Garske T, Ghani AC. Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS ONE 2010; 5: e15626.
32. Tranulis MA, Benestad SL, Baron T, Kretzschmar H. Atypical prion diseases in humans and animals. Top Curr Chem 2011; 305: 23-50.
33. Baylis M, Houston F, Kao RR etal. BSE - a wolf in sheep's clothing? Trends Microbiol 2002; 10: 563-570.
34. Stack M, Gonzalez L, Jeffrey M etal. Three serial passages of bovine spongiform encephalopathy in sheep do not significantly affect discriminatory tests. J Gen Virol 2009; 90: 764-768.
35. Sanders SE, Bartelt-Hunt SL, Bartz JC. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis 2012; 18: 369-376.
36. Collinge J. The risk of prion zoonoses. Science 2012; 335: 411-413.
37. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996; 383: 685-690.
38. Parchi P, Castellani R, Capellari S etal. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39: 767-778.
39. Parchi P, Giese A, Capellari S etal. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233.
40. Sc types: an updated classification. Acta Neuropathol 2009; 118: 659-671.
41. Gambetti P, Dong Z, Yuan J etal. Variably protease-sensitive prionopathy: a new sporadic disorder of the prion protein. Ann Neurol 2008; 63: 697-708.
42. Halfmann R, Lindquist S. Epigenetics in the extreme: prions and the inheritance of environmentally acquired traits. Science 2010; 330: 629-632.
43. Halfmann R, Jarosz DF, Jones SK etal. Prions are a common mechanism for phenotypic inheritance in wild yeast. Nature 2012; 482: 363-370.
44. Heinrich SU, Lindquist S. Protein-only mechanism induces self-perpetuating changes in the activity of neuronal Aplysia cytoplasmic polyadenylation element binding protein (CPEB). Proc Natl Acad Sci USA 2010; 108: 2999-3004.
45. Frost B, Ollesch J, Wille H, Diamond MI. Conformational diversity of wild-type tau fibrils specified by template conformational change. J Biol Chem 2009; 284: 3546-3551.
46. Desplats P, Lee HJ, Bae EJ etal. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc Natl Acad Sci USA 2009; 106: 13010-13015.
47. Nekooki-Machida Y, Kurosawa M, Nukina N, Ito T, Tanaka M. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci USA 2009; 106: 9678-9684.
48. Munch C, O'Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neural cells. Proc Natl Acad Sci USA 2011; 108: 3548-3553.
49. King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462: 61-80.
50. Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions and prionoids. Neuron 2009; 64: 783-790.
51. Frost B, Diamond MI. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 2010; 11: 155-159.
52. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimers disease and other neurodegenerative diseases. Ann Neurol 2011; 70: 530-540.
53. Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 2011; 147: 498-508.
54. Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010; 33: 317-325.
55. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123: 1191-1201.
56. Ridley RM, Baker HF, Windle CP, Cummings RM. Very long-term studies of the seeding of β-amyloids in primates. J Neural Transm 2006; 113: 1243-1251.
57. Meyer-Luehmann M, Coomaraswamy J, Bolmont T etal. Exongenous induction of cerebral β-amyloidogenesis is governed by host and agent. Science 2006; 313: 1781-1784.
58. Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C. De novo induction of amyloid-β deposition in vivo. Mol Psychiatry 2012; 17: 1347-1353. doi:10.1038/mp.2011.120.
59. Westerrmark GT, Westermark P. Prion-like aggregates: infectious agents in human disease. Trends Mol Med 2010; 16: 501-507.
60. Sc molecules with different conformations. Nat Med 1998; 4: 1157-1165.
61. Mahal SP, Demczyk CA, Smith EW, Klohn PC, Weissmann C. Assaying prions in cell culture: the standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA). Methods Mol Biol 2008; 459: 49-68.
62. Karapetyan YE, Saa P, Mahal SP etal. Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS ONE 2009; 4: e5730.
63. Li J, Browning S, Mahal S, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in culture. Science 2010; 327: 869-872.
64. Castilla J, Morales R, Saa P etal. Cell-free propagation of prion strains. EMBO J 2008; 27: 2557-2566.
65. Sc replication in vitro generates unique infectious prions. Cell 2008; 134: 757-768.
66. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104: 9741-9746.
67. Deleault NR, Walsh DJ, Piro JR etal. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci USA 2012; 109: 1938-1946.
68. Wang F, Zhang Z, Wang X etal. Genetic informational RNA is not required for recombinant prion infectivity. J Virol 2012; 86: 1874-1876.
69. Colby D, Prusiner SB. De novo generation of prion strains. Nat Rev Microbiol 2011; 9: 771-777.
70. Cali I, Castellani R, Alshekhlee A etal. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009; 132: 2643-2658.
71. Sc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 2005; 4: 805-814.
72. Yull H, Ritchie DL, Langeveld JP etal. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 2006; 168: 151-157.
73. Yull H, Ironside JW, Head MW. Further characterisation of the prion protein molecular types detectable in the NIBSC Creutzfeldt-Jakob disease brain reference materials. Biologicals 2009; 37: 210-215.
74. Kobayashi A, Sakuma N, Matsuura Y etal. Experimental verification of the traceback phenomenon in prion infection. J Virol 2010; 84: 3230-3238.
75. res in sporadic Creutzfeldt-Jakob disease MM1. Am J Pathol 2011; 178: 1309-1315.
76. res type 1 and 2 co-occurrence in sporadic CJD. Prion 2012; 6S: 129.
77. Parchi P, de Boni L, Saveroni D etal. Human prion disease histotype classification allows reliable identification of molecular subtypes: an inter-rate study among surveillance centres in Europe and USA. Acta Neuropathol 2012; 124: 517-529.
78. Head MW, Ironside JW. Sporadic Creutzfeldt-Jakob disease: discrete subtypes or a spectrum of disease? Brain 2009; 132: 2629-2629.
79. Zou WQ, Puoti G, Xiao X etal. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010; 68: 162-172.
80. Head MW, Knight R, Zeidler M etal. A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009; 35: 628-632.
81. Head MW, Lowrie S, Chohan G etal. Variably protease-sensitive prionopathy in a PRNP heterozygous UK patient with co-existing tau, α-synuclein and Aβ pathology. Acta Neuropathol 2010; 120: 821-823.
82. Head MW, Yull HM, Ritchie DL etal. Variably protease sensitive prionopathy in the United Kingdom. Clin Neuropathol 2012; 31: 272-273.
83. Safar JG, Geschwind MD, Deering C etal. Diagnosis of human prion diseases. Proc Natl Acad Sci USA 2005; 102: 3501-3506.
84. Choi YP, Groener A, Ironside JW, Head MW. Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob disease brain using conformation-dependent immunoassay and Western blot. J Gen Virol 2011; 92: 727-732.
85. Choi YP, Peden AH, Groener A, Ironside JW, Head MW. Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol 2010; 84: 12030-12038.
86. Legname G, Nguyen HOB, Peretz D etal. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 2006; 103: 19105-19110.
87. Colby DW, Giles K, Legname G etal. Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci USA 2009; 106: 20417-20422.
88. Colby DW, Wain R, Baskakov IV etal. Protease-sensitive prions. PLoS Pathog 2010; 6: e1000736.
89. Sasaki K, Minaki H, Iwaki T. Development of oligomeric prion protein aggregates in a mouse model of prion disease. J Pathol 2009; 219: 123-130.
90. Silviera JR, Raymond GJ, Hughson AG etal. The most infectious prion particles. Nature 2005; 437: 257-261.
91. Sc have different aggregation sizes in methionine homozygotes with sporadic, iatrogenic and variant Creutzfeldt-Jakob disease. J Gen Virol 2005; 86: 237-240.
92. Tixador P, Herzog L, Reine F etal. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 2010; 6: e1000859.
93. Kristiansen M, Deriziotis P, Dimcheff DE etal. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 2007; 26: 175-188.
94. Deriziotis P, Andre R, Smith DM etal. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J 2011; 30: 3056-3077.
95. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct phases. Nature 2011; 470: 540-542.
96. Zhou M, Ottenberg G, Sferrazza GF, Lasmezas CI. Highly neurotoxic monomeric α-helical prion protein. Proc Natl Acad Sci USA 2012; 109: 3113-3118.
97. Choi YP, Groener A, Ironside JW, Head MW. Correlation of polydispered prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species. Brain Pathol 2011; 21: 298-307.
98. Minaki H, Sasaki K, Honda H, Iwaki T. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns. Neuropathology 2009; 29: 536-542.
99. Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 2010; 107: 12005-12010.
100. Moda F, Suardi S, Di Frede G etal. MM2-thalamic Creutzfeldt-jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain. Brain Pathol 2012; 22: 662-669.
101. Sc type and PRNP genotype in an in-vitro conversion assay. Neuroreport 2008; 19: 1783-1786.
102. Kong Q, Huang S, Zou W etal. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 2005; 25: 7944-7949.
103. Padilla D, Beringue V, Espinosa JC etal. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog 2011; 7: e1001319.
104. Plinston C, Hart P, Chong A etal. Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy infection following passage in sheep. J Virol 2011; 85: 1174-1181.
105. Wilson R, Plinson C, Hunter N etal. Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J Gen Virol 2012; 93: 1624-1629.
106. Beringue V, Herzog L, Jaumain E etal. Facilitated cross-species transmission of prions in extraneural tissues. Science 2012; 335: 472-475.
107. Jones M, Wight D, Barron R etal. Molecular model of prion transmission to humans. Emerg Infect Dis 2009; 15: 2013-2016.
108. McCutcheon S, Alejo Blanco AR, Houston EF etal. All clinically relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS ONE 2011; 6: e231169.
109. Andreoletti O, Litaise C, Simmons H etal. Highly efficient prion transmission by blood transfusion. PLoS Pathog 2012; 8: e1002782.
110. Krejciova Z, Pells S, Cancellotti E etal. Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro. J Pathol 2011; 223: 635-645.